6 | RG7388IBA
01/2022
-
07/2014 |
6 | Phosphotransferases (Kinase)IBA
10/2017
-
11/2006 |
4 | Pharmaceutical PreparationsIBA
10/2017
-
05/2002 |
4 | AndrogensIBA
04/2013
-
05/2002 |
4 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2012
-
03/2009 |
4 | Capecitabine (Xeloda)FDA Link
01/2010
-
07/2007 |
3 | VemurafenibIBA
02/2012
-
07/2010 |
3 | Bevacizumab (Avastin)FDA Link
01/2009
-
07/2007 |
2 | RO6839921IBA
10/2020
-
01/2020 |
2 | ErbB Receptors (EGF Receptor)IBA
04/2016
-
06/2004 |
2 | Estrogen ReceptorsIBA
04/2016
-
07/2007 |
2 | Docetaxel (Taxotere)FDA Link
06/2015
-
09/2009 |
2 | Codon (Codons)IBA
02/2012
-
07/2010 |
2 | Proto-Oncogene Proteins B-rafIBA
01/2012
-
09/2010 |
2 | nutlin 3IBA
05/2011
-
02/2006 |
2 | Androgen Receptors (Androgen Receptor)IBA
05/2011
-
05/2002 |
2 | Proteins (Proteins, Gene)FDA Link
07/2010
-
05/2002 |
2 | Mitogen-Activated Protein KinasesIBA
01/2010
-
03/2009 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
01/2009
-
04/2007 |
2 | Tyrosine Kinase InhibitorsIBA
04/2007
-
06/2004 |
2 | Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2007
-
06/2004 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2006
-
10/2002 |
1 | PowdersIBA
12/2021 |
1 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 |
1 | Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2020 |
1 | ProdrugsIBA
01/2020 |
1 | Glucose (Dextrose)FDA LinkGeneric
11/2017 |
1 | DNA (Deoxyribonucleic Acid)IBA
10/2017 |
1 | pegfilgrastim (Neulasta)FDA Link
06/2015 |
1 | Filgrastim (Neupogen)FDA Link
06/2015 |
1 | RO8994IBA
08/2014 |
1 | RG7112IBA
04/2013 |
1 | Biomarkers (Surrogate Marker)IBA
04/2013 |
1 | Angiogenesis InhibitorsIBA
02/2013 |
1 | Intravenous Immunoglobulins (IVIG)FDA Link
08/2011 |
1 | AntitoxinsIBA
08/2011 |
1 | Bacterial ToxinsIBA
08/2011 |
1 | Immunoglobulin G (IgG)IBA
08/2011 |
1 | Immunoglobulins (Immunoglobulin)IBA
08/2011 |
1 | Interleukin-6 (Interleukin 6)IBA
06/2011 |
1 | Interleukin-8 (Interleukin 8)IBA
06/2011 |
1 | 2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
06/2011 |
1 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2011 |
1 | Hormones (Hormone)IBA
05/2011 |
1 | Protein Kinases (Protein Kinase)IBA
09/2010 |
1 | NocodazoleIBA
08/2010 |
1 | TubulinIBA
08/2010 |
1 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2010 |
1 | MitogensIBA
07/2010 |
1 | 2- (4- (4- (2,3- dihydroxy- propoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- N- (2- fluoro- 4- iodo- phenyl)- 3- phenylbutyramideIBA
01/2010 |
1 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2009 |
1 | (2S,3S)- 2- ((R)- 4- (4- (2- hydroxyethoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- 3- phenyl- N- (4- propionylthiazol- 2- yl)butyramideIBA
03/2009 |
1 | MAP Kinase Kinase 1IBA
03/2009 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2009 |
1 | Taxoids (Taxanes)IBA
07/2007 |
1 | AnthracyclinesIBA
07/2007 |
1 | Retinoblastoma ProteinIBA
11/2006 |
1 | Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2006 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2006 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2006 |
1 | RO0281501IBA
08/2006 |
1 | Gadolinium DTPA (Magnevist)FDA Link
08/2006 |
1 | Antineoplastic Agents (Antineoplastics)IBA
08/2006 |
1 | Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2006 |
1 | Biological ProductsIBA
04/2006 |
1 | Cisplatin (Platino)FDA LinkGeneric
06/2004 |
1 | GemcitabineFDA Link
06/2004 |
1 | Cytostatic AgentsIBA
10/2002 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
10/2002 |
1 | LigandsIBA
08/2002 |
1 | tanespimycin (17AAG)IBA
05/2002 |
1 | Androgen Antagonists (Antiandrogens)IBA
05/2002 |